SCHEMBL5696335

SCHEMBL5696335

O=c1[nH]c(=O)n(OCc2ccccc2)c(=O)[nH]1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
TSHR P16473 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.47
ALOX15 P16050 1/20 0.46
KDM4E B2RXH2 1/20 0.42
HBB P68871 1/20 0.42
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HPGD P15428 1/20 0.39
DAO P14920 2/20 0.39
MMP1 P03956 1/20 0.38
MMP2 P08253 1/20 0.38
MMP9 P14780 1/20 0.38
MMP12 P39900 1/20 0.38
TYMP P19971 1/20 0.38
IDO1 P14902 1/20 0.38
TK1 P04183 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10347428 0.80 ALDH1A1 (0.53) ALDH1A1TSHRSMN1; SMN2ALOX15KDM4E
SCHEMBL31285917 0.80 ALDH1A1 (0.53) ALDH1A1TSHRSMN1; SMN2ALOX15KDM4E
SCHEMBL3269756 0.78 ALDH1A1 (0.58) ALDH1A1TSHRSMN1; SMN2ALOX15KDM4E
SCHEMBL19812589 0.77 ALDH1A1 (0.47) ALDH1A1TSHRSMN1; SMN2ALOX15KDM4E
SCHEMBL6731313 0.77 ALDH1A1 (0.50) ALDH1A1TSHRSMN1; SMN2ALOX15KDM4E
SCHEMBL19812546 0.77 ALDH1A1 (0.47) ALDH1A1TSHRSMN1; SMN2ALOX15KDM4E
SCHEMBL19812557 0.77 ALDH1A1 (0.50) ALDH1A1TSHRSMN1; SMN2ALOX15KDM4E
SCHEMBL8151931 0.74 ALDH1A1 (0.50) ALDH1A1TSHRSMN1; SMN2ALOX15KDM4E
SCHEMBL19812572 0.74 ALDH1A1 (0.47) ALDH1A1TSHRSMN1; SMN2ALOX15KDM4E
Biphenyl SCHEMBL19812624 0.74 ALDH1A1 (0.47) ALDH1A1TSHRSMN1; SMN2ALOX15KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060241293-A1 Process for production n,n',n\"- trisubstituted isocyanuric acids DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2006-10-26 US disclosed
CN-1845910-A Process for production n,n',n''- trisubstituted isocyanuric acids DAICEL CHEM (JP) 2006-10-11 CN disclosed
EP-1666470-A1 PROCESS FOR PRODUCTION OF N,N';N''-TRISUBSTITUTED ISOCYANURIC ACIDS Daicel Chemical Industries, Ltd. (JP) 2006-06-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060241293-A1 Process for production n,n',n\"- trisubstituted isocyanuric acids NANS, NOS2, FASN ALDH1A1 618/4885TSHR 3872/4885SMN1; SMN2 2385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.